Envestnet Asset Management Inc Virios Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.24 - $0.44 $2,752 - $5,045	11,467 Added 10.5%	120,663 $44,000
Q4 2022 Feb 07, 2023	BUY	$0.24 - $0.39 $22,332 - $36,289	93,050 Added 576.3%	109,196 $26,000
Q3 2022 Nov 10, 2022	BUY	$0.37 - $8.77 $5,974 - $141,600	16,146 New	16,146 $6,000
Q2 2021 Aug 04, 2021	SELL	$4.71 - $6.95 $131,145 - $193,515	-27,844 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$5.01 - $8.84 $139,498 - $246,140	27,844 New	27,844 $160,000

1.12M

Ticker VIRI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,330,400
Market Cap $81.4M
Description
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.